(1)
wang, L. Clinical Progress of Targeted KRAS Drugs Combined With Immune Checkpoint Inhibitors in the Treatment of Pancreatic Cancer. TMBLS 2025, 8, 397-402. https://doi.org/10.62051/rq7x6r98.